Lilly’s 2026 dealmaking spreads the wealth among biotech venture investors
At least 50 different venture investors have benefited from Eli Lilly’s dealmaking this year, sending early investment dollars back into the startup ecosystem. On Monday, Lilly announced its 13th acquisition of the year, up to ...
Dave Ricks, Lilly CEO (Spencer Platt/Getty Images) September 1, 2026 11:01 AM EDT DealsPharma Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors Kyle LaHucik Biotech Correspondent At least 50 different venture investors have benefited from Eli Lilly’s dealmaking this year, sending early investment dollars back into the startup ecosystem. On Monday … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that